CRAG: de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing

Genome Med. 2022 Dec 8;14(1):138. doi: 10.1186/s13073-022-01141-8.

Abstract

The fine-scale cell-free DNA fragmentation patterns in early-stage cancers are poorly understood. We developed a de novo approach to characterize the cell-free DNA fragmentation hotspots from plasma whole-genome sequencing. Hotspots are enriched in open chromatin regions, and, interestingly, 3'end of transposons. Hotspots showed global hypo-fragmentation in early-stage liver cancers and are associated with genes involved in the initiation of hepatocellular carcinoma and associated with cancer stem cells. The hotspots varied across multiple early-stage cancers and demonstrated high performance for the diagnosis and identification of tissue-of-origin in early-stage cancers. We further validated the performance with a small number of independent case-control-matched early-stage cancer samples.

Keywords: Cancer early detection; Cell-free DNA; Fragmentation hotspots; Open chromatin regions; Tissues-of-origin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell-Free Nucleic Acids* / genetics
  • DNA Fragmentation
  • Humans

Substances

  • Cell-Free Nucleic Acids